In an update to the public last week, the FDA announced that all but one animal drug company have committed to seek withdrawal of approvals for any production uses of affected drug applications and change the remaining therapeutic uses of their products from over-the-counter to use by Veterinary Feed Directive or prescription. These changes stem from the implementation of FDA Guidance #213 that was announced in December of last year. The FDA is pleased with the strong responses received thus far and promises to continue to provide updates to the public. For the official announcement from the FDA, read here.
Industry Commitment For Antibiotic Resistance Strategy
Recent GVL Blog Posts
Indiana Accepts Extended Equine Certificate of Veterinary Inspection
Six-month horse health certificate program now includes IndianaEquine owners in Indiana have a new paperless option for interstate travel with their horses, as the state now accepts Extended Equine Certificates of Veterinary Inspection (EECVI). By allowing the use of...
Interstate Travel and Movement Compliance for Cattle – free CE webinar
As part of our interstate travel and movement compliance webinar series, we're focusing our next session on cattle.Amanda Price, DVM, MS Free CE webinar (1 hour)Interstate Travel and Movement Compliance for CattleWednesday, March 24, 2021 12:00 p.m. (CDT) In this...
Join us at this year’s AASV Annual (Virtual) Meeting
The GVL team is looking forward to the annual AASV Annual Meeting, a virtual conference. Don't miss these Industrial Partners Presentations.AASV Annual MeetingGVL - Tech Table ExhibitFebruary 27-March 2, 2021Virtual Learn more: aasv.orgSoftware Integrations provide...
